Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Francois-Clement Bidard
Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Related publications
Treating ER+ Breast Cancer With CDK4/6 Inhibitors
Cancer Discovery
Oncology
CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer
Cancer Discovery
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
Inhibitors Targeting CDK4/6, PARP and PI3K in Breast Cancer: A Review
Therapeutic Advances in Medical Oncology
Oncology
Loss of FAT1 Drives Resistance to CDK4/6 Inhibitors in Breast Cancer
Cancer Discovery
Oncology
Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer: Impact of CDK4/6 Inhibitors on the Current Treatment Paradigm
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
CDK4/6 Inhibitors for Hormone Receptor-Positive HER2-negative Metastatic Breast Cancer: Does One Size Fit All?
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Pcn81 - Budget Impact Analysis of Cdk4/6 Inhibitors for the First Line Theraphy of Hr-Positive Her2-Negative Advanced Breast Cancer in the Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Network Meta-Analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Oncology and Therapy
Oncology
